Results 21 to 30 of about 93,873 (261)

Correlations of Prostate Volume with PSA Levels in BPH Patients at Ulin General Hospital Banjarmasin

open access: yesBerkala Kedokteran, 2021
: This study aims to determine the association between prostate volume and PSA levels in BPH patients at Ulin Hospital Banjarmasin. This study used a cross-sectional retrospective approach and analytic method.
Nur Ramadhanti Cindy Levissa   +4 more
doaj   +1 more source

Targeting inflammation to reduce cardiovascular disease risk [PDF]

open access: yes, 2017
This joint themed section of the British Journal of Pharmacology and the British Journal of Clinical Pharmacology stems from a joint British Pharmacological Society – Italian Society of Pharmacology symposium held at the 37th National Congress of the ...
Cirino, Guiseppe, Maffia, Pasquale
core   +1 more source

Relationship Between Second to Fourth Digit Ratios and Benign Prostatic Hyperplasia in Aging Men [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2015
Introduction: Benign prostatic hyperplasia (BPH) is the most common prostate disease, characterized by benign enlargement of the prostate gland in aging men. Testosterone is said to be the major factor in development of BPH.
Hanumanthaiah Honnamachanahalli Sudhakar   +2 more
doaj   +1 more source

Interstitial laser therapy of benign prostatic hyperplasia [PDF]

open access: yes, 1999
The objective of interstitial laser coagulation (ILC) of benign prostatic enlargement is to achieve a marked volume reduction and to decrease bladder outlet obstruction and lower urinary tract symptoms with minimal morbidity.
Muschter, Rolf, Whitfield, Hugh
core   +1 more source

Management of Men With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia During and After COVID-19

open access: yesSociété Internationale d’Urologie Journal, 2021
The lower urinary tract (LUT), in particular the prostate, has been theoretically recognized as a target for SARS-CoV-2. Moreover, common pathophysiological mechanisms have been described for BPE/LUTS and COVID-19, including RAS dysregulation, androgen ...
Dean Elterman   +8 more
doaj   +1 more source

Combination therapy for benign prostate hyperplasia-related urinary symptoms

open access: yesВестник урологии, 2022
Introduction. Non-neurogenic lower urinary tract symptoms (LUTS) are a serious polyetiologic problem in the male population. The side effects of the medication agents used to treat LUTS significantly reduce treatment compliance.
S. V. Shkodkin   +6 more
doaj   +1 more source

Synthesis and characterization of nickel(II) maltolate complexes containing ancillary bisphosphine ligands [PDF]

open access: yes, 2011
Cationic nickel(II) complexes containing chelating O,O'-donor maltolate or ethyl maltolate ligands in conjunction with bidentate bisphosphine ligands Ph₂P(CH₂)nPPh₂ were prepared by a one-pot reaction starting from nickel(II) acetate, bisphosphine ...
Alblawi, Jamal   +2 more
core   +1 more source

Chemokines and BPH/LUTS [PDF]

open access: yesDifferentiation, 2011
A wealth of published studies indicate that a variety of chemokines are actively secreted by the prostatic microenvironment consequent to disruptions in normal tissue homeostasis due to the aging process or inflammatory responses. The accumulation of senescent stromal fibroblasts, and, possibly, epithelial cells, may serve as potential driving forces ...
openaire   +2 more sources

Thin-layer chromatography of pigments from reaction center particles of Rhodopseudomonas spheroides [PDF]

open access: yes, 1972
1. Pigments extracted from reaction center particles of Rhodopseudomonas spheroides were separated and identified by means of thin-layer chromatography.\ud \ud 2.
Barelds-van de Beek, P.G.M.M.   +2 more
core   +4 more sources

Home - About - Disclaimer - Privacy